The global hydrogel market size was USD 27.62 billion in 2023, estimated at USD 29.70 billion in 2024 and is anticipated to reach around USD 56.81 billion by 2034, growing at a CAGR of 6.7% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Hydrogel Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Hydrogel Market, by Raw Material, 2024-2034
8.1.1. Synthetic Hydrogels
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Natural Hydrogels
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Hybrid Hydrogels
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Hydrogel Market, by Composition Type, 2024-2034
9.1.1. Polyacrylate
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Polyacrylamide
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Silicone-modified Hydrogels
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Agar-based
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Hydrogel Market, by Form Type, 2024-2034
10.1.1. Amorphous Hydrogels
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Semi Crystalline Hydrogels
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Hydrogel Market, by Product Type, 2024-2034
11.1.1. Semi Crystalline Buttons
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Amorphous Gels
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Impregnated Gauze
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Films & Matrices
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Hydrogel Sheets
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. Hydrogel Market, by End User, 2024-2034
12.1.1. Hygiene Products
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Wound Care
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Drug Delivery
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Tissue Engineering
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.1.2. Market Revenue and Forecast, by Composition (2021-2034)
13.1.3. Market Revenue and Forecast, by Form (2021-2034)
13.1.4. Market Revenue and Forecast, by Product (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Composition (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Form (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Product (2021-2034)
13.1.7. Market Revenue and Forecast, by End User (2021-2034)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.1.8.2. Market Revenue and Forecast, by Composition (2021-2034)
13.1.8.3. Market Revenue and Forecast, by Form (2021-2034)
13.1.8.4. Market Revenue and Forecast, by Product (2021-2034)
13.1.8.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.2.2. Market Revenue and Forecast, by Composition (2021-2034)
13.2.3. Market Revenue and Forecast, by Form (2021-2034)
13.2.4. Market Revenue and Forecast, by Product (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Composition (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Form (2021-2034)
13.2.7. Market Revenue and Forecast, by Product (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Composition (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Form (2021-2034)
13.2.10. Market Revenue and Forecast, by Product (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Composition (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Form (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Product (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Composition (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Form (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Product (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.3.2. Market Revenue and Forecast, by Composition (2021-2034)
13.3.3. Market Revenue and Forecast, by Form (2021-2034)
13.3.4. Market Revenue and Forecast, by Product (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Composition (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Form (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Product (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Composition (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Form (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Product (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Composition (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Form (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Composition (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Form (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.4.2. Market Revenue and Forecast, by Composition (2021-2034)
13.4.3. Market Revenue and Forecast, by Form (2021-2034)
13.4.4. Market Revenue and Forecast, by Product (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Composition (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Form (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Product (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Composition (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Form (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Product (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Composition (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Form (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Composition (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Form (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.5.2. Market Revenue and Forecast, by Composition (2021-2034)
13.5.3. Market Revenue and Forecast, by Form (2021-2034)
13.5.4. Market Revenue and Forecast, by Product (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Composition (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Form (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Product (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Raw Material (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Composition (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Form (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
14.1. Cardinal Health
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Momentive Performance Materials
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. B. Braun Melsungen
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Derma Sciences
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Molnlycke Health Care
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Paul Hartmann
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Coloplast
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Johnson & Johnson
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Ocular Therapeutix
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Medline Industries
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client